NCT02600455View on ClinicalTrials.gov

Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL

CompletedOBSERVATIONAL
Enrollment

505

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Orencia

Trial Locations (1)

162-0822

Local Institution, Shinjuku-ku

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY